Instant access to deep knowledge on biologic drugs

Start your free trial now

Plans and Pricing

Details for Tradename: STELARA

Summary for Tradename: STELARA

Patents:4
Applicants:1
BLAs:1
Suppliers: see list1

Clinical Trials for: STELARA

A Study to Assess the Effect of Ustekinumab (Stelara®) and Etanercept (Enbrel®) in Participants With Moderate to Severe Psoriasis (MK-0000-206)
Status: Completed Condition: Psoriasis

A Pharmacokinetic Study of Single-Dose Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations
Status: Completed Condition: Healthy

A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Status: Not yet recruiting Condition: Colitis, Ulcerative; Inflammatory Bowel Diseases

A Study of the Safety and Efficacy of Ustekinumab in Adolescent Patients With Psoriasis (CADMUS)
Status: Completed Condition: Psoriasis

Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease
Status: Active, not recruiting Condition: Graft vs. Host Disease

A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus
Status: Not yet recruiting Condition: Systemic Lupus Erythematosus

Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris
Status: Recruiting Condition: Psoriasis

A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial Spondyloarthritis
Status: Not yet recruiting Condition: Axial Spondyloarthritis

A Study of the Effectiveness and Safety of Ustekinumab (STELARA) and CNTO 1959 Administered Under the Skin of Patients With Active Rheumatoid Arthritis, Despite Existing Methotrexate Therapy
Status: Completed Condition: Arthritis, Rheumatoid

A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type Psoriasis
Status: Completed Condition: Psoriasis

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Ingredient Dosage Form BLA Approval Date Patent No. Estimated Patent Expiration Status Orphan Source
Centocor Ortho Biotech Inc
STELARA
ustekinumab
INJECTABLE; INJECTION125261Sep 25, 20098,883,146<disabled in preview>Active Rxsearch
Centocor Ortho Biotech Inc
STELARA
ustekinumab
INJECTABLE; INJECTION125261Sep 25, 20098,962,804<disabled in preview>Active Rxsearch
Centocor Ortho Biotech Inc
STELARA
ustekinumab
INJECTABLE; INJECTION125261Sep 25, 20098,828,668<disabled in preview>Active Rxsearch
The preview shows a limited data set. Complete access is available with a Subscription

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC

Connect with Social Media:

Follow @BiologicPatents on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc